• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳头瘤病毒相关性口咽癌患者在诊断时和治疗后的优先事项。

Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, 601 N. Caroline Street, Baltimore, MD 21287, United States.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, 601 N. Caroline Street, Baltimore, MD 21287, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, United States; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, Baltimore, MD 21287, United States.

出版信息

Oral Oncol. 2019 Aug;95:11-15. doi: 10.1016/j.oraloncology.2019.05.016. Epub 2019 Jun 4.

DOI:10.1016/j.oraloncology.2019.05.016
PMID:31345377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6662631/
Abstract

INTRODUCTION

Little is known regarding how human papillomavirus-positive oropharyngeal cancer (HPV-OPC) patient goals change with treatment. This study evaluates whether patient ranking of non-oncologic priorities relative to cure and survival shift after treatment as compared to priorities at diagnosis.

MATERIALS AND METHODS

This is a prospective study of HPV-OPC patient survey responses at diagnosis and after treatment. The relative importance of 12 treatment-related priorities was ranked on an ordinal scale (1 as highest). Median rank (MR) was compared using Wilcoxon matched-pairs signed-rank tests. Prevalence of high concern for 11 treatment-related issues was compared using paired t-test. The effect of patient characteristics on change in priority rank and concern was evaluated using linear regression.

RESULTS

Among 37 patients, patient priorities were generally unchanged after treatment compared with at diagnosis, with cure and survival persistently ranked top priority. Having a moist mouth uniquely rose in importance after treatment. Patient characteristics largely did not affect change in priority rank. Concerns decreased after treatment, except concern regarding recurrence.

DISCUSSION

Treatment-related priorities are largely similar at diagnosis and after treatment regardless of patient characteristics. The treatment experience does not result in a shift of priorities from cure and survival to non-oncologic domains over cure and survival. The rise in importance of moist mouth implies that xerostomia may have been underappreciated as a sequelae of treatment. A decrease in most treatment-related concerns is encouraging, whereas the persistence of specific areas of concern may inform patient counseling.

摘要

简介

关于 HPV 阳性口咽癌(HPV-OPC)患者的治疗目标如何随治疗而改变,目前知之甚少。本研究评估了与治疗相比,患者在治疗后相对于治愈和生存对非肿瘤优先事项的排名是否发生变化。

材料和方法

这是一项 HPV-OPC 患者在诊断和治疗后的前瞻性研究。12 项与治疗相关的优先事项的相对重要性按序数量级(1 为最高)进行排名。使用 Wilcoxon 配对符号秩检验比较中位数秩(MR)。使用配对 t 检验比较 11 项与治疗相关问题的高关注度的发生率。使用线性回归评估患者特征对优先级排名和关注度变化的影响。

结果

在 37 名患者中,与诊断时相比,治疗后患者的优先事项基本保持不变,治愈和生存仍被列为首要任务。治疗后,口干的重要性独特地提高了。患者特征在很大程度上不会影响优先级排名的变化。治疗后,担忧程度降低,除了对复发的担忧。

讨论

无论患者特征如何,治疗相关的优先事项在诊断时和治疗后基本相似。治疗经历并不会导致优先事项从治愈和生存转移到非肿瘤领域,而超过治愈和生存。口腔干燥症的重要性上升意味着口干可能被低估为治疗的后遗症。大多数与治疗相关的担忧程度降低令人鼓舞,而对特定领域的担忧持续存在可能为患者咨询提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b70/6662631/79c83d9c75cb/nihms-1531417-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b70/6662631/4cea669f4ebd/nihms-1531417-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b70/6662631/79c83d9c75cb/nihms-1531417-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b70/6662631/4cea669f4ebd/nihms-1531417-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b70/6662631/79c83d9c75cb/nihms-1531417-f0002.jpg

相似文献

1
Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.人乳头瘤病毒相关性口咽癌患者在诊断时和治疗后的优先事项。
Oral Oncol. 2019 Aug;95:11-15. doi: 10.1016/j.oraloncology.2019.05.016. Epub 2019 Jun 4.
2
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.口腔冲洗液中持续人乳头瘤病毒 16 型 DNA 检测对人乳头瘤病毒相关口咽癌的预后意义。
JAMA Oncol. 2015 Oct;1(7):907-15. doi: 10.1001/jamaoncol.2015.2524.
3
Priorities, concerns, and regret among patients with head and neck cancer.头颈部癌症患者的优先事项、关注点和遗憾。
Cancer. 2019 Apr 15;125(8):1281-1289. doi: 10.1002/cncr.31920. Epub 2019 Jan 15.
4
Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.经口内镜下手术治疗后 p16 阳性口咽鳞状细胞癌的局部区域复发
Laryngoscope. 2021 Dec;131(12):E2865-E2873. doi: 10.1002/lary.29659. Epub 2021 Jun 2.
5
Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.经口切除人乳头瘤病毒(HPV)阳性口咽鳞状细胞癌:辅助治疗与无辅助治疗的结果。
Ann Surg Oncol. 2017 Nov;24(12):3494-3501. doi: 10.1245/s10434-017-6041-x. Epub 2017 Aug 14.
6
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.头颈癌的种族生存差异源于黑人口咽癌患者中人类乳头瘤病毒感染率较低。
Cancer Prev Res (Phila). 2009 Sep;2(9):776-81. doi: 10.1158/1940-6207.CAPR-09-0149. Epub 2009 Jul 29.
7
Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial.HPV 阳性口咽癌同步顺铂或西妥昔单抗放化疗:De-ESCALaTE HPV 试验的医疗资源利用、成本和校正质量调整生存。
Eur J Cancer. 2020 Jan;124:178-185. doi: 10.1016/j.ejca.2019.10.025. Epub 2019 Nov 30.
8
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 T cells.肿瘤浸润 B 细胞通过与 CD8 T 细胞的细胞间相互作用影响口咽鳞状细胞癌的进展。
J Immunother Cancer. 2019 Oct 17;7(1):261. doi: 10.1186/s40425-019-0726-6.
9
Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.人乳头瘤病毒相关性口咽癌的根治性手术:辅助治疗与无辅助治疗的生存结局比较。
Oral Oncol. 2018 Dec;87:170-176. doi: 10.1016/j.oraloncology.2018.10.039. Epub 2018 Nov 13.
10
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.低强度放化疗后 HPV 相关口咽癌低危患者的生活质量
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):646-653. doi: 10.1016/j.ijrobp.2018.10.033. Epub 2018 Nov 2.

引用本文的文献

1
Patient experience and shared decision-making in HPV-positive oropharyngeal cancer: A systematic review of qualitative and quantitative evidence.人乳头瘤病毒阳性口咽癌患者的体验与共同决策:定性和定量证据的系统评价
Clin Transl Radiat Oncol. 2025 Aug 6;55:101028. doi: 10.1016/j.ctro.2025.101028. eCollection 2025 Nov.
2
Survivors' perspectives on cisplatin-induced ototoxicity and barriers to ototoxicity monitoring.幸存者对顺铂所致耳毒性及耳毒性监测障碍的看法。
J Cancer Surviv. 2025 Jul 2. doi: 10.1007/s11764-025-01860-y.
3
Quality of Life and Patient-Reported Outcomes Following Proton Therapy for Oropharyngeal Carcinoma: A Systematic Review.

本文引用的文献

1
Priorities, concerns, and regret among patients with head and neck cancer.头颈部癌症患者的优先事项、关注点和遗憾。
Cancer. 2019 Apr 15;125(8):1281-1289. doi: 10.1002/cncr.31920. Epub 2019 Jan 15.
2
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.低强度放化疗后 HPV 相关口咽癌低危患者的生活质量
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):646-653. doi: 10.1016/j.ijrobp.2018.10.033. Epub 2018 Nov 2.
3
Self-reported oral morbidities in long-term oropharyngeal cancer survivors: A cross-sectional survey of 906 survivors.
口咽癌质子治疗后的生活质量和患者报告结局:一项系统评价
Cancers (Basel). 2023 Apr 12;15(8):2252. doi: 10.3390/cancers15082252.
4
Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.开发一个基于网络的、以患者为中心的口咽癌治疗决策辅助工具。
Oral Oncol. 2021 Dec;123:105618. doi: 10.1016/j.oraloncology.2021.105618. Epub 2021 Nov 22.
5
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development.评估头颈部鳞状细胞癌患者的偏好:问卷开发的第一阶段和第二阶段
Cancers (Basel). 2020 Nov 30;12(12):3577. doi: 10.3390/cancers12123577.
6
Value and Quality of Care in Head and Neck Oncology.头颈部肿瘤学中的医疗价值与质量。
Curr Oncol Rep. 2020 Jul 10;22(9):92. doi: 10.1007/s11912-020-00952-5.
7
The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020.头颈部癌症护理的演变:2020年的科学现状
Cancers (Basel). 2020 Jun 11;12(6):1543. doi: 10.3390/cancers12061543.
长期口咽癌幸存者的自我报告口腔疾病:对 906 名幸存者的横断面调查。
Oral Oncol. 2018 Sep;84:88-94. doi: 10.1016/j.oraloncology.2018.07.006. Epub 2018 Jul 26.
4
Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.口咽癌不再是年轻患者的疾病,HPV (人乳头瘤病毒)在老年患者中的预后优势减弱:国家癌症数据库分析。
Oral Oncol. 2018 Aug;83:147-153. doi: 10.1016/j.oraloncology.2018.06.013. Epub 2018 Jun 27.
5
Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.人乳头瘤病毒阳性口咽癌在老年人群中发病率不断上升。
Cancer. 2018 Jul 15;124(14):2993-2999. doi: 10.1002/cncr.31385. Epub 2018 Apr 30.
6
Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery.对头颈部外科临床试验中使用的患者报告结局工具的结构化综述。
Br J Oral Maxillofac Surg. 2018 Apr;56(3):161-167. doi: 10.1016/j.bjoms.2017.10.019. Epub 2018 Feb 1.
7
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.患者自述口干:用于相关性分析的仪器比较和模型表现,以及对头颈癌幸存者生活质量的影响。
Radiother Oncol. 2018 Jan;126(1):75-80. doi: 10.1016/j.radonc.2017.10.037. Epub 2017 Dec 8.
8
Organ-Sparing in Radiotherapy for Head-and-Neck Cancer: Improving Quality of Life.头颈部癌症放射治疗中的器官保护:提高生活质量。
Semin Radiat Oncol. 2018 Jan;28(1):46-52. doi: 10.1016/j.semradonc.2017.08.002.
9
Fear of cancer recurrence in oral and oropharyngeal cancer patients: An investigation of the clinical encounter.口腔和口咽癌患者对癌症复发的恐惧:临床问诊调查
Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12785. Epub 2017 Oct 12.
10
Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒相关口咽鳞状细胞癌减量化放化疗患者报告的口干症和吞咽困难的剂量学预测因素
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1022-1027. doi: 10.1016/j.ijrobp.2017.03.034. Epub 2017 Mar 27.